The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Recent Advances in Arsenic Carcinogenesis: Modes of Action, Animal Model Systems, and Methylated Arsenic Metabolites
Abstract
Recent advances in our knowledge of arsenic carcinogenesis include the development of rat or mouse models for all human organs in which inorganic arsenic is known to cause cancer-skin, lung, urinary bladder, liver, and kidney. Tumors can be produced from either promotion of carcinogenesis protocols (mouse skin and lungs, rat bladder, kidney, liver, and thyroid) or from complete carcinogenesis protocols (rat bladder and mouse lung). Experiments with p53(+/-) and K6/ODC transgenic mice administered dimethylarsinic acid or arsenite have shown some degree of carcinogenic, cocarcinogenic, or promotional activity in skin or bladder. At present, with the possible exception of skin, the arsenic carcinogenesis models in wild-type animals are more highly developed than in transgenic mice. Recent advances in arsenic metabolism have suggested that methylation of inorganic arsenic may be a toxification, rather than a detoxification, pathway and that trivalent methylated arsenic metabolites, particularly monomethylarsonous acid and dimethylarsinous acid, have a great deal of biological activity. Accumulating evidence indicates that these trivalent, methylated, and relatively less ionizable arsenic metabolites may be unusually capable of interacting with cellular targets such as proteins and even DNA. In risk assessment of environmental arsenic, it is important to know and to utilize both the mode of carcinogenic action and the shape of the dose-response curve at low environmental arsenic concentrations. Although much progress has been recently made in the area of arsenic's possible mode(s) of carcinogenic action, a scientific concensus has not yet been reached. In this review, nine different possible modes of action of arsenic carcinogenesis are presented and discussed-induced chromosomal abnormalities, oxidative stress, altered DNA repair, altered DNA methylation patterns, altered growth factors, enhanced cell proliferation, promotion/progression, gene amplification, and suppression of p53.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Monomethylarsonous Acid (MMAIII) Is More Toxic Than Arsenite in Chang Human Hepatocytes
Petrick, J. S., Ayala-Fierro, F., Cullen, W. R., Carter, D. E., & Vasken Aposhian, H. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8872 · Cited by 716
Arsenic: health effects, mechanisms of actions, and research issues.
Abernathy, C. O., Liu, Y. P., Longfellow, D., Aposhian, H. V., Beck, B., Fowler, B., Goyer, R., Menzer, R., Rossman, T., Thompson, C., et al. (1999) · Environmental Health Perspectives · doi:10.1289/ehp.99107593 · Cited by 657
Zhao, C. Q., Young, M. R., Diwan, B. A., Coogan, T. P., & Waalkes, M. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10907 · Cited by 559
Reviews in biochemical toxicology
Ecobichon, D. J. (1979) · Pesticide Biochemistry and Physiology · doi:10.1016/0048-3575(79)90115-9 · Cited by 506
O'Brien, T. G. (1976) · PubMed · Cited by 437
Tanaka, K., Miura, N., Satokata, I., Miyamoto, I., Yoshida, M. C., Satoh, Y., Kondo, S., Yasui, A., Okayama, H., & Okada, Y. (1990) · Nature · doi:10.1038/348073a0 · Cited by 388
Brien, T. G. (1976) · Cited by 354
Speciation of Key Arsenic Metabolic Intermediates in Human Urine
Le, X. C., Lu, X., Ma, M., Cullen, W. R., Aposhian, H. V., & Zheng, B. (2000) · Analytical Chemistry · doi:10.1021/ac000527u · Cited by 332
Mass, M. J., & Wang, L. (1997) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(97)00008-2 · Cited by 309
Comparative Inhibition of Yeast Glutathione Reductase by Arsenicals and Arsenothiols
Styblo, M., Serves, S. V., Cullen, W. R., & Thomas, D. J. (1997) · Chemical Research in Toxicology · doi:10.1021/tx960139g · Cited by 299
Vega, L., Styblo, M., Patterson, R., Cullen, W., Wang, C., & Germolec, D. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9152 · Cited by 291
Reviews in biochemical toxicology
Hodgson, E., Bend, J. R., & Philpot, R. M. (1979) · Elsevier eBooks · Cited by 274
Occurrence of Monomethylarsonous Acid in Urine of Humans Exposed to Inorganic Arsenic
Aposhian, H. V., Gurzau, E. S., Le, X. C., Gurzau, A., Healy, S. M., Lu, X., Ma, M., Yip, L., Zakharyan, R. A., Maiorino, R. M., et al. (2000) · Chemical Research in Toxicology · doi:10.1021/tx000114o · Cited by 265
Yamamoto, S., Konishi, Y., Matsuda, T., Murai, T., Shibata, M., Matsui‐Yuasa, I., Otani, S., Kuroda, K., Endo, G., & Fukushima, S. (1995) · PubMed · Cited by 242
Ornithine Decarboxylase: A Key Regulatory Enzyme in Normal and Neoplastic Growth
Russell, D. H. (1985) · Drug Metabolism Reviews · doi:10.3109/03602538508991430 · Cited by 241
Methylarsenicals and Arsinothiols Are Potent Inhibitors of Mouse Liver Thioredoxin Reductase
Lin, S., Cullen, W. R., & Thomas, D. J. (1999) · Chemical Research in Toxicology · doi:10.1021/tx9900775 · Cited by 230
Species differences in the metabolism of arsenic compounds
Vahter, M. (1994) · Applied Organometallic Chemistry · doi:10.1002/aoc.590080304 · Cited by 230
Yamanaka, K., Hoshino, M., Okamoto, M., Sawamura, R., Hasegawa, A., & Okada, S. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91674-h · Cited by 223
Arsenic Species That Cause Release of Iron from Ferritin and Generation of Activated Oxygen
Ahmad, S., Kitchin, K. T., & Cullen, W. R. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2023 · Cited by 215
Self-citationInduction of Gene Amplification by Arsenic
Lee, T.-C., Tanaka, N., Lamb, P. W., Gilmer, T. M., & Barrett, J. C. (1988) · Science · doi:10.1126/science.3388020 · Cited by 211
A concise review of the toxicity and carcinogenicity of dimethylarsinic acid
Kenyon, E. M., & Hughes, M. F. (2001) · Toxicology · doi:10.1016/s0300-483x(00)00458-3 · Cited by 202
Arsenic Enhancement of Skin Neoplasia by Chronic Stimulation of Growth Factors
Germolec, D. R., Spalding, J., Yu, H.-S., Chen, G. S., Simeonova, P. P., Humble, M. C., Bruccoleri, A., Boorman, G. A., Foley, J. F., Yoshida, T., et al. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65692-1 · Cited by 200
Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats
Wei, M., Wanibuchi, H., Yamamoto, S., Li, W., & Fukushima, S. (1999) · Carcinogenesis · doi:10.1093/carcin/20.9.1873 · Cited by 190
Matsui, M., Nishigori, C., Imamura, S., Miyachi, Y., Toyokuni, S., Takada, J., Akaboshi, M., & Ishikawa, M. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00630.x · Cited by 189
Hu, Y., Su, L., & Snow, E. T. (1998) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(98)00035-4 · Cited by 184
Cherney, B. W., McBride, O. W., Chen, D. F., Alkhatib, H., Bhatia, K., Hensley, P., & Smulson, M. E. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8370 · Cited by 180
Warner, M. L., Moore, L. E., Smith, M. T., Kalman, D. A., Fanning, E., & Smith, A. H. (1994) · PubMed · Cited by 157
Biochemical toxicology of arsenic.
Aposhian, H. (1989) · Europe PMC (PubMed Central) · Cited by 155
Carcinogenesis Modeling: From Molecular Biology to Epidemiology
Moolgavkar, S. H. (1986) · Annual Review of Public Health · doi:10.1146/annurev.pu.07.050186.001055 · Cited by 148
Jones, J. S., Weber, S. C., & Prakash, L. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.14.7119 · Cited by 147
Aposhian, H. V., Zheng, B., Aposhian, M. M., Le, X. C., Cebrián, M. E., Cullen, W., Zakharyan, R. A., Ma, M., Dart, R. C., Cheng, Z., et al. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2000.8922 · Cited by 145
Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors
Germolec, D. R., Spalding, J. W., Boorman, G. A., Wilmer, J. L., Yoshida, T., Simeonova, P. P., Bruccoleri, A., Kayama, F., Gaido, K. W., Tennant, R. W., et al. (1997) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(97)00006-9 · Cited by 145
Is the Genotoxic Effect of Arsenic Mediated by Oxygen Free Radicals?
Nordenson, I., & Beckman, L. E. (1991) · Human Heredity · doi:10.1159/000153979 · Cited by 137
Sequences of Escherichia coli uvrA gene and protein reveal two potential ATP binding sites.
Husain, I., Houten, B. V., Thomas, D. C., & Sancar, A. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89189-5 · Cited by 134
Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms?
Simeonova, P. P., & Luster, M. I. (2000) · PubMed · Cited by 130
Yamanaka, K., & Okada, S. (1994) · Environmental Health Perspectives · doi:10.1289/ehp.94102s337 · Cited by 130
Wanibuchi, H., Yamamoto, S., Chen, H., Yoshida, K., Endo, G., Hori, T., & Fukushima, S. (1996) · Carcinogenesis · doi:10.1093/carcin/17.11.2435 · Cited by 130
Zhong, C., & Mass, M. J. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(01)00365-4 · Cited by 121
Mechanism of comutagenesis of sodium arsenite withn-methyl-n-nitrosourea
Li, J. H., & Rossman, T. G. (1989) · Biological Trace Element Research · doi:10.1007/bf02917278 · Cited by 113
Inhibition of poly(ADP-ribose) polymerase by arsenite
Yager, J. W., & Wiencke, J. K. (1997) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(97)00011-2 · Cited by 110
Effects of Arsenic Cell Metabolism and Cell Proliferation: Cytogenetic and Biochemical Studies
Petres, J., Baron, D., & Hagedorn, M. (1977) · Environmental Health Perspectives · doi:10.1289/ehp.7719223 · Cited by 95
Induction of p53 protein expression by sodium arsenite
Salazar, A. M., Ostrosky‐Wegman, P., Menéndez, D., Miranda, E., García-Carrancá, A. M., & Rojas, E. (1997) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(97)00207-8 · Cited by 88
Carcinogenicity: Testing: Predicting, and Interpreting Chemical Effects
Kitchin, K. T. (1998) · Cited by 85
Self-citationMonomethylarsonic Acid Reductase and Monomethylarsonous Acid in Hamster Tissue
Sampayo‐Reyes, A., Zakharyan, R. A., Healy, S. M., & Aposhian, H. V. (2000) · Chemical Research in Toxicology · doi:10.1021/tx000154s · Cited by 84
Arsenic Disrupts Cellular Levels of p53 and mdm2: A Potential Mechanism of Carcinogenesis
Hamadeh, H. K., Vargas, M., Lee, E. B., & Menzel, D. B. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1395 · Cited by 81
Calcium-dependent nitric oxide production is involved in arsenite-induced micronuclei
Gurr, J.-R., Liu, F., Lynn, S., et al. (1998) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(98)00076-x · Cited by 80
Effects of dietary dimethylarsinic acid on the urine and urothelium of rats
Arnold, L. L., Cano, M., John, M. S., Eldan, M., van Gemert, M., & Cohen, S. M. (1999) · Carcinogenesis · doi:10.1093/carcin/20.11.2171 · Cited by 74
Hsu, C.-H., Yang, S.-A., Wang, J.-Y., Yu, H.-S., & Lin, S.-R. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690467 · Cited by 72
Hayashi, H., Kanisawa, M., Yamanaka, K., et al. (1998) · Cancer Letters · doi:10.1016/s0304-3835(97)00484-9 · Cited by 70
Urothelial Cytotoxicity and Regeneration Induced by Dimethylarsinic Acid in Rats
Cohen, S. M. (2001) · Toxicological Sciences · doi:10.1093/toxsci/59.1.68 · Cited by 69
Yamanaka, K., Katsumata, K., Ikuma, K., et al. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00440-1 · Cited by 66
Expression of p53 in Arsenic-Related and Sporadic Basal Cell Carcinoma
Boonchai, W., Walsh, M. D., Cummings, M. C., & Chenevix‐Trench, G. (2000) · Archives of Dermatology · doi:10.1001/archderm.136.2.195 · Cited by 61
K6/ODC transgenic mice as a sensitive model for carcinogen identification
Chen, Y., Megosh, L. C., Gilmour, S. K., Sawicki, J. A., & O’Brien, T. G. (2000) · Toxicology Letters · doi:10.1016/s0378-4274(00)00196-x · Cited by 58
Possible carcinogenic potential of dimethylarsinic acid as assessed in rat in vivo models: a review
Yamamoto, S., Wanibuchi, H., Hori, T.-A., Yano, Y., Matsui‐Yuasa, I., Otani, S., Chen, H., Yoshida, K., Kuroda, K., Endo, G., et al. (1997) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(97)00017-3 · Cited by 54
Kitchin, K. T., Razo, L. M. D., Brown, J. L., Anderson, W. L., & Kenyon, E. M. (1999) · Teratogenesis Carcinogenesis and Mutagenesis · doi:10.1002/(sici)1520-6866(1999)19:6 · Cited by 44
Self-citationInfrequent p53 mutations in arsenic-related skin lesions.
Castrén, K., Ranki, A., Ja, W., & Vähäkangas, K. (1998) · PubMed · Cited by 41
Cited by
Arsenic: toxicity, oxidative stress and human disease
Jomova, K., Jenisova, Z., Feszterova, M., Baros, S., Liska, J., Hudecova, D., Rhodes, C. J., & Valko, M. (2011) · Journal of Applied Toxicology · doi:10.1002/jat.1649 · Cited by 1,431
Arsenic Exposure and Toxicology: A Historical Perspective
Hughes, M. F., Beck, B. D., Chen, Y., Lewis, A. S., & Thomas, D. J. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr184 · Cited by 1,312
Aquatic arsenic: Toxicity, speciation, transformations, and remediation
Sharma, V. K., & Sohn, M. (2009) · Environment International · doi:10.1016/j.envint.2009.01.005 · Cited by 1,119
Redox- and non-redox-metal-induced formation of free radicals and their role in human disease
Valko, M., Jomova, K., Rhodes, C. J., Kuča, K., & Musílek, K. (2016) · Archives of Toxicology · doi:10.1007/s00204-015-1579-5 · Cited by 1,022
Heavy metals: toxicity and human health effects
Jomova, K., Alomar, S. Y., Nepovimova, E., Kuca, K., & Valko, M. (2025) · Archives of Toxicology · doi:10.1007/s00204-024-03903-2 · Cited by 983
Metadata
- Authors
- Kitchin, K. T.
- Venue
- Toxicology and Applied Pharmacology
- Publisher
- Elsevier BV
- Published
- 2001-05
- Volume
- 172
- Issue
- 3
- Pages
- 249-261
- ISSN
- 0041-008X (ISSN-L)
- OpenAlex
- W2035029439
- Cited by
- 792
- References
- 57
- FWCI
- 39.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.